Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.
Keating GM.
Pharmacoeconomics. 2011 Jun;29(6):535-43. doi: 10.2165/11207430-000000000-00000. Review.
Related citations
Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors.
Latimer N, Lord J, Grant RL, O'Mahony R, Dickson J, Conaghan PG.
Pharmacoeconomics. 2011 Mar;29(3):225-37. doi: 10.2165/11584200-000000000-00000.
Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.
Barkun AN, Adam V, Sung JJ, Kuipers EJ, Mössner J, Jensen D, Stuart R, Lau JY, Nauclér E, Kilhamn J, Granstedt H, Liljas B, Lind T.
Pharmacoeconomics. 2010;28(3):217-30. doi: 10.2165/11531480-000000000-00000.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on